Tuesday, September 16, 2014 8:26:25 AM
Milestone Scientific and Milestone China Form New Dermatological Joint Venture
LIVINGSTON, NJ--(Marketwired - September 16, 2014) - Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced it has formed a dermatological joint venture with Milestone China. The new joint venture entity, Milestone Advanced Cosmetic Systems, Inc., will be 50% owned by Milestone Scientific and 50% owned by Milestone China. Milestone China will contribute $900,000 and Milestone Scientific will contribute a limited license to use its technology to the joint venture for the development of a botox injection system, consisting of a computer controlled injection device and a related disposable. As previously announced, Milestone China is a joint venture distribution company between Milestone Scientific and a team headed by a senior healthcare executive from China. The focus of Milestone China is to supply and distribute medical and dental instruments, and disposables to China and other Asian markets.
The joint venture will have exclusive world-wide rights to the botox drug delivery system, which will be based on the patented, painless, computer-controlled injection and drug delivery technology originally developed by Milestone Scientific. Milestone Scientific will be responsible for sales and distribution of the instrument in the USA and Europe, while Milestone China will oversee sales and distribution of the instrument in China and other parts of Asia. The joint venture plans to commence development of the device and disposable within the next ninety days.
Leonard Osser, Chief Executive Officer of Milestone Scientific, stated, "Our new joint venture represents the next step of expanding our intellectual property and proven technology into new markets. Botox injections represent a growing multi-billion dollar worldwide market. However, the procedure can be painful and can result in complications due to improper drug delivery. We believe our system will help address these challenges and should be well received by the market as a painless and effective means of drug delivery. Milestone China is an ideal strategic partner, as the principals have extensive expertise and proven track records launching new medical devices in China. This latest agreement reinforces our strategy of leveraging our core technology, and strategically entering new markets while minimizing dilution for shareholders."
Lidong Zhang, Chief Executive Officer of Milestone China, added, "With over 50 million injections delivered to date, Milestone Scientific's painless, computer controlled injection and drug delivery technology is ideally suited to address the botox market. We look forward to working with Milestone Scientific to develop the Botox delivery system and help launch the product in China and Asia. We believe this technology has the potential to become the standard of care, as medical practitioners realize the safety and medical benefits of this system."
About Milestone Scientific Inc.
Milestone Scientific Inc. is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
Recent MLSS News
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida • GlobeNewswire Inc. • 04/03/2024 12:30:00 PM
- Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023 • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 03/28/2024 03:45:00 PM
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians • GlobeNewswire Inc. • 03/14/2024 12:30:00 PM
- Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio • GlobeNewswire Inc. • 02/28/2024 01:30:00 PM
- Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast • GlobeNewswire Inc. • 02/20/2024 01:30:00 PM
- Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update • GlobeNewswire Inc. • 01/16/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:34:33 PM
- Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock • GlobeNewswire Inc. • 12/13/2023 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2023 05:01:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:29 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/12/2023 10:10:53 PM
- Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock • GlobeNewswire Inc. • 12/11/2023 01:33:45 AM
- Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 12/08/2023 09:03:25 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/08/2023 09:00:28 PM
- Milestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures • GlobeNewswire Inc. • 12/08/2023 01:30:00 PM
- Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain • GlobeNewswire Inc. • 11/28/2023 01:30:00 PM
- Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023 • GlobeNewswire Inc. • 11/15/2023 12:00:00 PM
- Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 11/10/2023 01:30:00 PM
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York • GlobeNewswire Inc. • 11/09/2023 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/31/2023 04:15:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 09:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 09:39:33 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/19/2023 06:36:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/17/2023 08:03:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM